The latest Japanese version expands electronic data capture to incorporate real-time, trial management reporting and analysis
Tokyo (BUSINESS WIRE) - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the availability of a new Japanese version of its electronic data capture (EDC) solution, InForm J Integrated Trial Management (ITM).
The new Japanese version offers comprehensive, real-time trial management reporting and analysis capabilities embedded directly into the product - providing clinical organizations with the ability to help enhance the execution and management of clinical trials, and improve and accelerate clinical decision-making.
Since 2003, Phase Forward's InForm J solution has been used by life sciences companies of all sizes to help efficiently collect, manage and clean clinical data, and has been leveraged in more than 110 trials in Japan.
"Our customers require innovative, sophisticated clinical data capture and management tools to support today's increasingly complex trials, and the benefits afforded by improved clinical trial productivity and efficiencies," said Steve Powell, senior vice president, Worldwide Sales at Phase Forward.
"InForm J meets that requirement by offering real-time visibility into data and the ability to more effectively analyze the data, process reports and ultimately take appropriate action."
New product features include: Comprehensive Reporting and Analysis Capabilities - with its intuitive drag-and-drop interface, InForm J provides a robust and flexible set of out-of-the-box reporting and analysis tools.
An extensive library of trial reports, including 32 dynamic and fully configurable trial management reports and 18 new reports specifically designed to assist monitors with site management, are provided to help clinical staff track metrics such as eCRF completion status, source verification progress and query cycle times.
The InForm J solution also has powerful ad hoc reporting tools, enabling end-users to create and publish reports easily without the need for extensive report customization or IT assistance.
Unlike competitive offerings that require additional software, strong technical expertise, or custom report development from the EDC solution vendor - which result in added costs and time delays - the new release of the InForm J solution puts reporting into the hands of those directly responsible for running the study - the study teams.
Team members can further streamline trial management by creating personal homepages with tailored views of data such as summary snapshots covering a variety of trial metrics.
Productivity Enhancements
Across All Clinical Roles - for monitors, remote access to detailed and up-to-the-minute site status allows for better visit planning to minimize travel and maximize effectiveness while on site. A monitor can run reports on data entry, query rates and response times, form completion, and signature status, to plan for an upcoming site visit. These efficiency gains allow monitors to work with more sites and support additional trials, improving overall workflow and productivity in the clinical process.
With InForm J ITM, project managers are able to gain a real-time view of critical clinical events, such as adverse events or protocol violations, and can proactively monitor patient recruitment to identify slow enrollment or high dropout levels or track and trigger payment milestones. In addition, managers are better able to manage contract research organizations (CROs) and other trial partners through direct access to externally collected data.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm), phase I clinic automation (LabPas), clinical data management (Clintrial), clinical trials signal detection (CTSD), strategic pharmacovigilance (WebVDME? and Signal Management), adverse event reporting (Empirica? Trace) and applied data standards (WebSDM?).
In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards.
Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
for Phase Forward Katsuhiko Niga, +81 35276 4372
Tokyo (BUSINESS WIRE) - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the availability of a new Japanese version of its electronic data capture (EDC) solution, InForm J Integrated Trial Management (ITM).
The new Japanese version offers comprehensive, real-time trial management reporting and analysis capabilities embedded directly into the product - providing clinical organizations with the ability to help enhance the execution and management of clinical trials, and improve and accelerate clinical decision-making.
Since 2003, Phase Forward's InForm J solution has been used by life sciences companies of all sizes to help efficiently collect, manage and clean clinical data, and has been leveraged in more than 110 trials in Japan.
"Our customers require innovative, sophisticated clinical data capture and management tools to support today's increasingly complex trials, and the benefits afforded by improved clinical trial productivity and efficiencies," said Steve Powell, senior vice president, Worldwide Sales at Phase Forward.
"InForm J meets that requirement by offering real-time visibility into data and the ability to more effectively analyze the data, process reports and ultimately take appropriate action."
New product features include: Comprehensive Reporting and Analysis Capabilities - with its intuitive drag-and-drop interface, InForm J provides a robust and flexible set of out-of-the-box reporting and analysis tools.
An extensive library of trial reports, including 32 dynamic and fully configurable trial management reports and 18 new reports specifically designed to assist monitors with site management, are provided to help clinical staff track metrics such as eCRF completion status, source verification progress and query cycle times.
The InForm J solution also has powerful ad hoc reporting tools, enabling end-users to create and publish reports easily without the need for extensive report customization or IT assistance.
Unlike competitive offerings that require additional software, strong technical expertise, or custom report development from the EDC solution vendor - which result in added costs and time delays - the new release of the InForm J solution puts reporting into the hands of those directly responsible for running the study - the study teams.
Team members can further streamline trial management by creating personal homepages with tailored views of data such as summary snapshots covering a variety of trial metrics.
Productivity Enhancements
Across All Clinical Roles - for monitors, remote access to detailed and up-to-the-minute site status allows for better visit planning to minimize travel and maximize effectiveness while on site. A monitor can run reports on data entry, query rates and response times, form completion, and signature status, to plan for an upcoming site visit. These efficiency gains allow monitors to work with more sites and support additional trials, improving overall workflow and productivity in the clinical process.
With InForm J ITM, project managers are able to gain a real-time view of critical clinical events, such as adverse events or protocol violations, and can proactively monitor patient recruitment to identify slow enrollment or high dropout levels or track and trigger payment milestones. In addition, managers are better able to manage contract research organizations (CROs) and other trial partners through direct access to externally collected data.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm), phase I clinic automation (LabPas), clinical data management (Clintrial), clinical trials signal detection (CTSD), strategic pharmacovigilance (WebVDME? and Signal Management), adverse event reporting (Empirica? Trace) and applied data standards (WebSDM?).
In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards.
Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
for Phase Forward Katsuhiko Niga, +81 35276 4372
No comments:
Post a Comment